Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells

Cancer Research

Volumn 57, Issue 5, 1997, Pages 978-987

  Sartor, Carolyn I ^a   Dziubinski, Michele L ^a   Yu, Chao Lan ^b   Jove, Richard ^b   Ethier, Stephen P ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; BREAST CANCER; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL DIVISION; DNA-BINDING PROTEINS; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; MIDDLE AGED; PHOSPHOTYROSINE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RNA, NEOPLASM; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0031025240     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumour suppressor gene. Nature (Lond.), 351: 453-456, 1991.
2. Dougall, W. C., Qian, X. L., Peterson, N. C., Miller, M. J., Samanta, A., and Greene, M. I. The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene, 9: 2109-2123, 1994.
3. Cance, W. G., and Liu, E. T. Protein kinases in human breast cancer. Breast Cancer Res. Treat., 35: 105-114, 1995.
4. Ethier, S. P. Growth factor synthesis and human breast cancer progression. J. Natl. Cancer Inst., 87: 964-973, 1995.
5. Hammond, S. L., Ham, R. G., and Stampfer, M. R. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc. Natl, Acad. Sci. USA, 81: 5435-5439, 1984.
6. Smith, H. S., Lan, S., Ceriani, R., Hackett, A. J., and Stampfer, M. R. Clonal proliferation of cultured nonmalignant and malignant human breast epithelia. Cancer Res., 41: 4637-4643, 1981.
7. Stampfer, M. R., Hallowes, R. C., and Hackett. A. J. Growth of normal human mammary epithelial cells in culture. In Vitro, 16: 415-425, 1980.
8. Band, V., and Sager, R. Distinctive traits of normal and tumor derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc. Natl. Acad. Sci. USA, 86: 1249-1253, 1989.
9. Ethier, S. P., Summerfelt, R. M., Cundiff, K. C., and Asch, B. B. The influence of growth factors on the proliferative potential of normal and primary breast cancer-derived human breast epithelial cells. Breast Cancer Res. Treat., 17: 221-230, 1990.
10. Ethier, S. P., Mahacek, M. L., Gullick, W. J., Frank, T. J., and Weber, B. L. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res., 53: 627-635, 1993.
11. Huguet, E. L., Smith, K., Bicknell, R., and Harris, A. L. Regulation of Wnt5a mRNA expression in human mammary epithelial cells by cell shape, confluence, and hepatocyte growth factor. J. Biol. Chem., 270: 12851-12856, 1995.
12. Petersen, O. W., Ronnovjessen, L., Howlett, A. R., and Bissell, M. J. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. USA. 89: 9064-9068, 1992.
13. Berdichevsky, F., Alford, D., Dsouza, B., and Taylorpapadimitriou, J. Branching morphogenesis of human mammary epithelial cells in collagen gels. J. Cell Sci., 107: 3557-3568, 1994.
14. Mahacek, M. L., Beer, D. G., Frank, T. S., and Ethier, S. P. Finite proliferative lifespan in vitro of a human breast cancer cell strain isolated from a metastatic lymph node. Breast Cancer Res. Treat., 28: 267-276, 1993.
15. Ethier, S. P., Kokeny, K. E., Ridings, J. E., and Dilts, C. A. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. Cancer Res., 56: 899-907, 1996.
16. Battaglia, F., Scambia, G., Rossi, S., Panici, P. B., Bellantone, R., Polizzi, G., Querzoli, P., Negrini, R., lacobelli, S., Crucitti, F., and Mancuso, S. Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement. Eur. J. Cancer Clin. Oncol., 24: 1685-1690, 1988.
17. Palette, N., Lefebvre, M. F., Meggouh, F., Eynard, M., Garin, E., and Saez, S. Measurement of occupied and non-occupied epidermal growth factor receptor sites in 216 human breast cancer biopsies. Breast Cancer Res. Treat., 20: 177-183, 1992.
18. Harris, A. L., Nicholson, S., Sainsbury, J. R. C., Farndon, J., and Wright, C. Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu. J. Steroid Biochem., 34: 123-131, 1989.
19. Moller, P., Mechtersheimer, G., Kaufmann, M., Moldenhauer, G., Momburg, F., Mattfeldt, T., and Otto, H. F. Expression of epidermal growth factor receptor in benign and malignant primary tumours of the breast. Vichows Archiv. A Pathol. Anat., 414: 157-164, 1989.
20. Nicholson, S., Halcrow, P., Farndon, J. R., Sainsbury, J. R. C., Chambers, P., and Harris, A. L. Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer, Lancet, 8631: 182-185, 1989.
21. Nicholson, S., Richard, J., Sainsbury, C., Halcrow, P., Kelly, P., Angus, B., Wright, C., Henry, J., Farndon, J. R., and Harris, A. L. Epidermal growth factor receptor (EGFr) - results of a six year follow-up study in operable breast cancer with emphasis on the node negative subgroup. Br. J. Cancer. 63: 146-150, 1991.
22. Toi, M., Hamada, Y., Nakamura, T., Mukaida, H., Suehiro, S., Wada, T., Toge, T., Nimoto, M., and Hattori, T. Immunocytochemical and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: relationship to estrogen receptor and lymphatic invasion. Int. J. Cancer, 43: 220-225, 1989.
23. Zeillinger, R., Kury, F., Czerwenka, K., Kubista, E., Sliutz, G., Knogler, W., Huber, J., Zielinski, C., Reiner, G., Jakesz, R., Staffen, A., Reiner, A., Wrba, F., and Spona, J. HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. Oncogene. 4: 109-114, 1989.
24. Yu, C., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., and Jove, R. Enhanced DNA-binding activity of EL Stat3-related protein in cells transformed by the Src oncoprotein. Science (Washington DC). 269: 81-83, 1995.
25. Ceriani, R. L., Peterson, J. A., Blank, E. W., and Lamport, D. T. A. Epitope expression on the breast epithelial mucin. Breast Cancer Res. Treat., 24: 103-113, 1992.
26. Bartek, J., Papadimitriou, J. T., Miller, N., and Millis, R. Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumors. Int. J. Cancer, 36: 299-306, 1985.
27. Dairkee, S. H., Puett, L., and Hackett, A. J. Expression of basal and luminal epithelium-specific keratins in normal, benign and malignant breast tissue. J. Natl. Cancer Inst., 80: 691-695, 1988.
28. Fry, D. W., Kraker, A. J., McMichael, A., Amoroso, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., and Bridges, A. J. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science (Washington DC), 265: 1093-1095, 1994.
29. Ethier, S. P., Moorthy, R., and Dilts, C. A. Secretion of an epidermal growth factor-like growth factor by epidermal growth factor-independent rat mammary carcinoma cells. Cell Growth & Differ., 2: 593-602, 1991.
30. Ethier, S. P., and Moorthy, R. Multiple growth factor independence in rat mammary carcinoma cells. Breast Cancer Res. Treat., 18: 73-81, 1991.
31. Mitamura, T., Higashiyama, S., Taniguchi, N., Klagsbrun, M., and Mekada, E. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity, J. Biol. Chem., 270: 1015-1019, 1995.
32. Naglich, J. C., Metherall, J. E., Russell, D. W., and Eidels, L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell, 69: 1051-1061, 1992.
33. Ruff-Jamison, S., Chen, K., and Cohen, S. Epidermal growth factor induces the tyrosine phosphorylation and nuclear translocation of Stat 5 in mouse liver. Proc. Natl. Acad. Sci. USA, 92: 4215-4218, 1995.
34. Helm, M. H., Kerr, I. M., Stark, G. R., and Darnell, J. E., Jr. Contribution of STAT SH2 groups to specific Interferon signaling by the Jak-STAT pathway. Science (Washington DC), 267: 1347-1349, 1995.
35. Ruff-Jamison, S., Chen, K., and Cohen, S. Induction by EGF and interferon-γ of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. Science (Washington DC), 261: 1733-1736, 1993.
36. Zhong, Z., Wen, Z., and Darnell, J. E., Jr. Stat3, a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science (Washington DC), 264: 95-98, 1994.
37. Tourkine, N., Schindler, C., Larose, M., and Houdebine, L. M. Activation of STAT factors by prolactin, interferon-γ, growth hormones, and a tyrosine phosphatase inhibitor in rabbit primary mammary epithelial cells. J. Biol. Chem., 270: 20952-20961, 1995.
38. Darnell, J. J. E., Kerr, I. M., and Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (Washington DC), 264: 1415-1421, 1994.
39. Filmus, F., Pollak, M. N., Cailleau, R., and Buick, R. MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem. Biophys. Res. Commun., 128: 898-905, 1985.
40. Ennis, B. W., Valverius, E. M., Bates, S. E., Lippman, M. E., Ballot, F., Kris, R., Schlessinger, J., Masui, H., Goldenberg, A., Mendelsohn, J., and Dickson, R. B. Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimuluted growth of MDA-468 human breast cancer cells. Mol. Endocrinol., 3: 1830-1838, 1989.
41. Ethier, S. P., Langton, B. C., and Dilts, C. A. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-α. Mol. Carcinog., 15: 134-143, 1996.
42. Hashimoto, K., Higashiyama, S., Asada, H., Hashimura, E., Kobayashi, T., Sudo, K., Nakagawa, T., Damm, D., Yoshikawa, K., and Taniguchi, N. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J. Biol. Chem., 269: 20060-20066, 1994.
43. Higashiyama, S., Abraham, J. A., Miller, J., Fiddes, J. C., and Klagsbrun, M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science (Washington DC), 251: 936-939, 1991.
44. Higashiyama, S., Abraham, J. A., and Klagsbrun, M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J. Cell Biol., 122: 933-940, 1993.
45. Abraham, J. A., Damm, D., Bajardi, A., Miller, J., Klagsbrun, M., and Ezekowitz, R. A. B. Heparin-binding EGF-like growth factor: characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues, Biochem, Biophys. Res. Commun., 190: 125-133, 1993.
46. Raab, G., Higashiyama, S., Hetelekidis, S., Abraham, J. A., Damm, D., Ono, M., and Klagsbrun, M. Biosynthesis and processing by phorbol ester of the cell surface-associated precursor form of heparin-binding EGF-like growth factor. Biochem. Biophys. Res. Commun., 204: 592-597, 1994.
47. Higashiyama, S., Iwamoto, R., Goishi, K., Raab, G., Taniguchi, N., Klagsbrun, M., and Mekada, E. The membrane protein CDB/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J. Cell Biol., 128: 929-938, 1995.
48. Nakamura, K., Iwamoto, R., and Mekada, E. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin α3β1 at cell-cell contact sites. J. Cell Biol., 129: 1691-1705, 1995.
49. Zhang, Z., Funk, C., Glasser, S. R., and Mulholland, J. Progesterone regulation of heparin-binding epidermal growth factor-like growth factor gene expression during sensitization and decidualization in the rat uterus: effects of the antiprogestin ZK 98.299. Endocrinology, 135: 1256-1265, 1994.
50. Wang, X., Das, S. K., Damm, D., Klagsbrun, M., Abraham, J. A., and Dey, S. K. Differential regulation of heparin-binding epidermal growth factor-like growth factor in the adult ovariectomized mouse uterus by progesterone and estrogen. Endocrinology, 135: 1264-1271, 1994.
51. Fu, X. Y., and Zhang, J. J. Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter. Cell, 74: 1135-1145, 1993.
52. Sadowski, H. B., and Gilman, M. Z. Cell-free activation of a DNA-binding protein by epidermal growth factor. Nature (Lond.), 362: 79-83, 1993.
53. Shuai, K., Horvath, C. M., Huang, L. H. T., Qureshi, S. A., Cowburn, D., and Darnell, J. E. Interferon activation of the transcription factor Stat91 involves dimerization through Sh2-phosphotyrosyl peptide interactions. Cell, 76: 821-828, 1994.
54. Lamer, A. C., David, M., Feldman, G. M., Igarashi, K., Hacken, R. H., Webb, D. S. A., Sweitzer, S. M., Petricoin, E. F., and Finbloom, D. S. Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science (Washington DC), 261: 1730-1733, 1993.
55. Hill, C. S., and Treismun, R. Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. EMBO J., 14: 5037-5047, 1995.
56. Hill, C. S., and Treisman, R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell. 80: 199-211, 1995.
57. Sadowski, H. B., Shuai, K., Darnell, J. E., Jr., and Gilman, M. Z. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science (Washington DC), 261: 1739-1744, 1993.
58. Leaman, D. W., Pisharody, S., Flickinger, T. W., Commune, M. A., Schlessinger, J., Kerr, I. M., Levy, D. E., and Stark, G. R. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol. Cell. Biol., 16: 369-375, 1996.
59. Watson, C. J., and Miller, W. R. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br. J. Cancer. 71: 840-844, 1995.